SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-24-020196
Filing Date
2024-02-26
Accepted
2024-02-26 16:30:35
Documents
54
Period of Report
2024-02-26
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K dawn-20240226.htm   iXBRL 8-K 46438
2 EX-99.1 dawn-ex99_1.htm EX-99.1 85729
3 EX-99.2 dawn-ex99_2.htm EX-99.2 47867
4 GRAPHIC img109617361_0.jpg GRAPHIC 9664
5 GRAPHIC dawn-ex99_2s1.jpg GRAPHIC 222308
6 GRAPHIC dawn-ex99_2s2.jpg GRAPHIC 651376
7 GRAPHIC dawn-ex99_2s3.jpg GRAPHIC 417942
8 GRAPHIC dawn-ex99_2s4.jpg GRAPHIC 315813
9 GRAPHIC dawn-ex99_2s5.jpg GRAPHIC 239623
10 GRAPHIC dawn-ex99_2s6.jpg GRAPHIC 343086
11 GRAPHIC dawn-ex99_2s7.jpg GRAPHIC 449699
12 GRAPHIC dawn-ex99_2s8.jpg GRAPHIC 414734
13 GRAPHIC dawn-ex99_2s9.jpg GRAPHIC 349987
14 GRAPHIC dawn-ex99_2s10.jpg GRAPHIC 417422
15 GRAPHIC dawn-ex99_2s11.jpg GRAPHIC 272882
16 GRAPHIC dawn-ex99_2s12.jpg GRAPHIC 313022
17 GRAPHIC dawn-ex99_2s13.jpg GRAPHIC 471460
18 GRAPHIC dawn-ex99_2s14.jpg GRAPHIC 433207
19 GRAPHIC dawn-ex99_2s15.jpg GRAPHIC 305306
20 GRAPHIC dawn-ex99_2s16.jpg GRAPHIC 278788
21 GRAPHIC dawn-ex99_2s17.jpg GRAPHIC 404122
22 GRAPHIC dawn-ex99_2s18.jpg GRAPHIC 396752
23 GRAPHIC dawn-ex99_2s19.jpg GRAPHIC 417434
24 GRAPHIC dawn-ex99_2s20.jpg GRAPHIC 296490
25 GRAPHIC dawn-ex99_2s21.jpg GRAPHIC 374398
26 GRAPHIC dawn-ex99_2s22.jpg GRAPHIC 213250
27 GRAPHIC dawn-ex99_2s23.jpg GRAPHIC 417963
28 GRAPHIC dawn-ex99_2s24.jpg GRAPHIC 248960
29 GRAPHIC dawn-ex99_2s25.jpg GRAPHIC 539233
30 GRAPHIC dawn-ex99_2s26.jpg GRAPHIC 437856
31 GRAPHIC dawn-ex99_2s27.jpg GRAPHIC 381118
32 GRAPHIC dawn-ex99_2s28.jpg GRAPHIC 103436
33 GRAPHIC dawn-ex99_2s29.jpg GRAPHIC 350829
34 GRAPHIC dawn-ex99_2s30.jpg GRAPHIC 264411
35 GRAPHIC dawn-ex99_2s31.jpg GRAPHIC 355747
36 GRAPHIC dawn-ex99_2s32.jpg GRAPHIC 344397
37 GRAPHIC dawn-ex99_2s33.jpg GRAPHIC 424590
38 GRAPHIC dawn-ex99_2s34.jpg GRAPHIC 433891
39 GRAPHIC dawn-ex99_2s35.jpg GRAPHIC 338434
40 GRAPHIC dawn-ex99_2s36.jpg GRAPHIC 378685
41 GRAPHIC dawn-ex99_2s37.jpg GRAPHIC 345613
42 GRAPHIC dawn-ex99_2s38.jpg GRAPHIC 466808
43 GRAPHIC dawn-ex99_2s39.jpg GRAPHIC 310666
  Complete submission text file 0000950170-24-020196.txt   19807612

Data Files

Seq Description Document Type Size
44 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT dawn-20240226.xsd EX-101.SCH 23892
55 EXTRACTED XBRL INSTANCE DOCUMENT dawn-20240226_htm.xml XML 4552
Mailing Address 2000 SIERRA POINT PARKWAY, SUITE 501 BRISBANE CA 94005
Business Address 2000 SIERRA POINT PARKWAY, SUITE 501 BRISBANE CA 94005 650 484-0899
Day One Biopharmaceuticals, Inc. (Filer) CIK: 0001845337 (see all company filings)

IRS No.: 832415215 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40431 | Film No.: 24679397
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)